Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
Sungju Jung, Sumin Yoon, Jong Hoon Park, Yeon-Su Lee, Kyung Hyun Yoo
No abstract text is available yet for this article.
February 23, 2024: Clinical and Molecular Hepatology
#22
EDITORIAL
Moon Haeng Hur, Jeong-Hoon Lee
No abstract text is available yet for this article.
February 23, 2024: Clinical and Molecular Hepatology
#23
EDITORIAL
Atsumasa Komori
No abstract text is available yet for this article.
February 23, 2024: Clinical and Molecular Hepatology
#24
EDITORIAL
Chen-Te Huang, Tai-Chung Tseng
No abstract text is available yet for this article.
February 22, 2024: Clinical and Molecular Hepatology
#25
EDITORIAL
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
No abstract text is available yet for this article.
February 22, 2024: Clinical and Molecular Hepatology
#26
JOURNAL ARTICLE
Hyeyeon Hong, Jonggi Choi
No abstract text is available yet for this article.
February 21, 2024: Clinical and Molecular Hepatology
#27
JOURNAL ARTICLE
Michael Le, Linda Henry, Mindie H Nguyen
No abstract text is available yet for this article.
February 19, 2024: Clinical and Molecular Hepatology
#28
JOURNAL ARTICLE
Chaerin Woo, Won-Il Jeong
No abstract text is available yet for this article.
February 19, 2024: Clinical and Molecular Hepatology
#29
JOURNAL ARTICLE
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
No abstract text is available yet for this article.
February 19, 2024: Clinical and Molecular Hepatology
#30
EDITORIAL
Pin-Nan Cheng, Ming-Lung Yu
No abstract text is available yet for this article.
February 19, 2024: Clinical and Molecular Hepatology
#31
EDITORIAL
Carlos Jose Pirola, Silvia Sookoian
No abstract text is available yet for this article.
February 5, 2024: Clinical and Molecular Hepatology
#32
EDITORIAL
Lung-Yi Mak
No abstract text is available yet for this article.
February 2, 2024: Clinical and Molecular Hepatology
#33
JOURNAL ARTICLE
Yun-Fan Liaw
No abstract text is available yet for this article.
January 31, 2024: Clinical and Molecular Hepatology
#34
JOURNAL ARTICLE
Tsubasa Tsutsumi, Dan Nakano, Machiko Kawaguchi, Hirokazu Takahashi, Takumi Kawaguchi
No abstract text is available yet for this article.
January 30, 2024: Clinical and Molecular Hepatology
#35
JOURNAL ARTICLE
Sumin Oh, Yang-Hyun Baek, Sungju Jung, Sumin Yoon, Byeonggeun Kang, Su-Hyang Han, Gaeul Park, Je Yeong Ko, Sang-Young Han, Jin-Sook Jeong, Jin-Han Cho, Young-Hoon Roh, Sung-Wook Lee, Gi-Bok Choi, Yong Sun Lee, Won Kim, Rho Hyun Seong, Jong Hoon Park, Yeon-Su Lee, Kyung Hyun Yoo
BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by fat accumulation in the liver. MASLD encompasses both steatosis and MASH. Since MASH can lead to cirrhosis and liver cancer, steatosis and MASH must be distinguished during patient treatment. Here, we investigate the genomes, epigenomes, and transcriptomes of MASLD patients to identify signature gene set for more accurate tracking of MASLD progression. METHODS: Biopsy-tissue and blood samples from patients with 134 MASLD, comprising 60 steatosis and 74 MASH patients were performed omics analysis...
January 26, 2024: Clinical and Molecular Hepatology
#36
JOURNAL ARTICLE
Michael H Le, David M Le, Thomas C Baez, Hansen Dang, Vy H Nguyen, KeeSeok Lee, Christopher D Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H Nguyen
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is associated with a multitude of adverse outcomes. We aimed to estimate the pooled incidence of NAFLD-related adverse events. METHODS: We performed a systematic review and meta-analysis of cohort studies of adults with NAFLD to evaluate the pooled incidence of adverse events. RESULTS: 19,406 articles were screened, 409 full-text articles reviewed, and 79 eligible studies (1,377,466 persons) were included...
January 26, 2024: Clinical and Molecular Hepatology
#37
JOURNAL ARTICLE
Michihiro Iwaki, Hideki Fujii, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
BACKGROUND/AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently proposed as an alternative disease concept to nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prognosis in patients with biopsy-confirmed MASLD using data from a multicenter study. METHODS: This is a sub-analysis of the CLIONE (Clinical Outcome Nonalcoholic Fatty Liver Disease) study, included 1,398 patients with NAFLD. Liver biopsy specimens were pathologically diagnosed, and histologically scored using the NASH Clinical Research Network system...
January 24, 2024: Clinical and Molecular Hepatology
#38
JOURNAL ARTICLE
Byoung Kuk Jang
No abstract text is available yet for this article.
April 2024: Clinical and Molecular Hepatology
#39
JOURNAL ARTICLE
Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
No abstract text is available yet for this article.
April 2024: Clinical and Molecular Hepatology
#40
JOURNAL ARTICLE
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
No abstract text is available yet for this article.
April 2024: Clinical and Molecular Hepatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
